| Neurocognition and Borderline Personality Disorder: Status and Future Directions |
2005; 11(1) |
9-13 |
Fertuck, Eric A. (New York State Psychiatric Institute) |
| Antibiotics in acute and chronic coronary syndromes |
2005; 11(1) |
4-7 |
Vainas, Tryfon (University Hospital of Maastricht) |
| Endocannabinoid System - Myth or Magic |
2005; 11(1) |
3 |
Nutt, Prof. David (Psychopharmacology Unit, University of Bristol, UK) |
| Effects of ultrafine carbon particles in healthy subjects and subjects with asthma |
2005; 11(1) |
8-9 |
Peters, PD Dr. Annette (Insititute of Epidemiology, Neuherberg) |
| Lateralizing and Localizing Ictal Signs and Symptoms |
2003; 9(1) |
13 - 17 |
Rosenow, Prof. Felix (Universität Marburg) |
| Long Term Outcome after Temporal Lobe Epilepsy Surgery in Children |
2003; 9(1) |
10 - 13 |
Dlugos, D. J. (Children's Hospital of Philadelphia; The) |
| Monitoring Neuronal Damage in Temporal Lobe Epilepsy with Magnetic Resonance Imaging and Spectroscopy |
2003; 9(1) |
6 -9 |
Bernasconi, Dr. A. (Montreal Neurological Hospital and Institute) |
| Pathways to Psychopathology in Epilepsy |
2003; 9(1) |
20-24 |
Haverkamp, Prof. F. (Universität Bonn) |
| Interictal Epileptiform EEG-discharges in Children with Temporal Lobe Epilepsy |
2003; 9(1) |
17-20 |
Haverkamp, Prof. F. (Universität Bonn) |
| Is Epilepsy a Progressive Disease |
2003; 9(1) |
2 |
Theodore, William H. (Epilepsy Research Branch, NINDS) |
| Epidemiologie der Arthrose |
2002; 8: Suppl: 1 |
2-3 |
Pientka, PD Dr. L. (Bochum) |
| Differentialdiagnostik in der Rheumatologie |
2002; 8: Suppl: 1 |
4-7 |
Burmester, Prof. Dr. G.-R. (Charite) |
| Coxibe: Ähnlichkeiten und Unterschiede |
2002; 8: Suppl: 1 |
8-9 |
Brune, Prof. Dr. K. (Universität Erlangen) |
| Update 1: Statine und Myopathie-Risiko |
2002; 8(3): |
87-91 |
Farmer, John A M.D. (Baylor College Houston) |
| Statine: Überlegungen zu Indikation und Behandlungssicherheit nach Kenntnis von Daten der MRC/BHF Heart Protection Study |
2002; 8(3): |
68-71 |
Klose, Prof. Dr. G. (Klinikum links der Weser) |
| Editorial |
2002; 8(3): |
67 |
Katus, Prof. Dr. H.A. (Universitätsklinik Lübeck) |
| Neue Aspekte in der Sekundärprävention |
2002; 8(3): |
72-73 |
Hodenberg, Prof. Dr. E. von (Herzzentrum Lahr) |
| Pharmakologie der Statine |
2002; 8(3): |
82-86 |
Bergmann, Prof. Dr. K von (Universtitätsklinik Bonn) |
| Kardioprotektion bei Hochrisikopatienten |
2002; 8(3): |
78-79 |
Haass, Prof. Dr. M (Uniklinik Heidelber) |
| Molekulare Pathogenese der Atherosklerose |
2002; 8(3): |
92-94 |
Thiery, Prof. Dr. Joachim (Universität Leipzig) |
| Herzinfarkt- und Schlaganfallrisiko bei Diabetikern – Eine therapeutische Chance durch Lipidtherapie |
2002; 8(3): |
74-77 |
Windler, Prof. Dr. Eberhard (Universitätsklinik Hamburg) |
| Herzinfarkt- und Schlaganfallrisiko bei älteren Patienten |
2002; 8(3): |
80-81 |
Steinhagen-Thiessen, Prof. (Geriatriezentrum Berlin) |
| Taking stock of pancreatic stem cells |
2002; 8(2): |
51-52 |
Gruss, Prof. Dr. (Universität Giessen) |
| CI Therapy: A New Rehabilitation Technique for Aphasia and Motor Disability after Neurological Injury |
2002; 8(2): |
48-49 |
Taub, Edward Ph.D. |
| Treatment of autoimmune diseases by hemopoietic stem cell transplantation |
2002; 8(2): |
|
Ikehara, Prof. S. (Kansai Medical University, Osaka ) |
| Resectable rectal cancer: Is radiotherapy still an option? |
2002; 8(1): |
21 |
Edwards, ChM FRCSEd D. (Frimley Park Hospital) |
| Platelet Glycoprotein IIb/IIIa Inhibition and Management Strategies in Unstable Angina and Myocardial Infarction without ST Segment Elevation |
2002; 8(1): |
7-8 |
Kugelmass, Dr. Aaron (University of OK HSC) |
| The optimal long term treatment of deep venous thrombosis |
2002; 8(1): |
|
Prandoni; Prof. Paolo (University of Padua) |
| Congress and Cloning: A brief lesson in how not to make policy |
2002; 8(1): |
27 |
Burley, J (Oxford Univerity) |
| Verantwortung für Arzneimittelsicherheit |
2002; 8(1): |
38-39 |
Wartensleben, H. (Rechstanwaltskanzlei) |
| Measurement of C-Reactive Protein for the targeting of statin therapy in the primary prevention of acute coronary events |
2002; 8(1): |
|
Haverkate, Dr. F (University of Leiden) |
| Stem Cells for the Failing Heart - Does ACE Inhibition Interfere? |
2002; 8(1): |
10-13 |
Maisch, Prof. Bernhard (Molecular Cardiology Laboratory,
Philipps University of Marburg) |
| Statins and Myotoxicity: potential mechanism and clinical implications |
2002; 8(1): |
34-36 |
Farmer, John A M.D. (Baylor College Houston) |
| Welche Risiken birgt die Therapie mit NSAR |
2001; 7: Suppl: 2: |
2-3 |
Pientka, PD Dr. L. (Bochum) |
